Together, mTOR signaling promotes the PEG-mediated CCL2 expression in both tumor cells and macrophages, thereby regulating macrophages chemotaxis to the tumor and acts as a potential target for anti-tumor immunotherapy. Here, CCL2 is linked to neoplasm.